We are live on ! Find out more
CS

Cannell & Spears Portfolio holdings

AUM $5.1B
1-Year Est. Return 31.77%
This Fund
S&P 500
This Quarter Est. Return
+6.04%
1 Year Est. Return
+31.77%
3 Year Est. Return
+94.5%
5 Year Est. Return
+108.17%
10 Year Est. Return
+357.88%
AUM
$779M
AUM Growth
-$16M
Cap. Flow
-$52.7M
Cap. Flow %
-6.77%
Top 10 Hldgs %
45.57%
Holding
142
New
15
Increased
21
Reduced
57
Closed
10

Top Buys

Rank Stock Value
1
ADNT icon
Adient
ADNT
+$1.47M
2
IBB icon
iShares Biotechnology ETF
IBB
+$1.3M
3
K
Kellanova
K
+$678K
4
KMB icon
Kimberly-Clark
KMB
+$615K
5
MJN
Mead Johnson Nutrition Company
MJN
+$584K

Top Sells

Rank Stock Value
1
AGN
Allergan plc
AGN
+$7.69M
2
AIG icon
American International
AIG
+$3.92M
3
CB icon
Chubb
CB
+$3.59M
4
CMCSA icon
Comcast
CMCSA
+$2.91M
5
APTV icon
Aptiv
APTV
+$2.86M

Sector Composition

Rank Sector Weight
1 Financials 28.55%
2 Healthcare 18.07%
3 Technology 14.24%
4 Industrials 13.86%
5 Consumer Discretionary 9.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FTV icon
26
Fortive
FTV
$19B
$8.38M 1.08%
247,625
-49,809
-17% -$1.65M
JNJ icon
27
Johnson & Johnson
JNJ
$635B
$5.9M 0.76%
51,214
+2,283
+5% +$264K
AXS icon
28
AXIS Capital
AXS
$8.59B
$4.9M 0.63%
75,071
– –
UNH icon
29
UnitedHealth
UNH
$382B
$3.78M 0.49%
23,626
+3,095
+15% +$462K
SPY icon
30
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$3.01M 0.39%
13,461
+554
+4% +$121K
UNB icon
31
Union Bankshares
UNB
$114M
$2.78M 0.36%
61,191
-969
-2% -$37.7K
XOM icon
32
ExxonMobil
XOM
$651B
$2.66M 0.34%
29,479
-2,153
-7% -$188K
BRK.B icon
33
Berkshire Hathaway Class B
BRK.B
$1.07T
$2.11M 0.27%
12,924
+308
+2% +$47.4K
AON icon
34
Aon
AON
$77.3B
$2.07M 0.27%
18,541
– –
BIIB icon
35
Biogen
BIIB
$29.9B
$2.02M 0.26%
7,115
-126
-2% -$37.4K
WFC icon
36
Wells Fargo
WFC
$261B
$1.92M 0.25%
34,902
+678
+2% +$34.1K
CVS icon
37
CVS Health
CVS
$137B
$1.86M 0.24%
23,560
– –
KMI icon
38
Kinder Morgan
KMI
$73.1B
$1.81M 0.23%
87,232
-1,758
-2% -$37.2K
PG icon
39
Procter & Gamble
PG
$343B
$1.74M 0.22%
20,738
+40
+0.2% +$3.41K
ADNT icon
40
Adient
ADNT
$1.6B
$1.64M 0.21%
+27,920
New +$1.47M
TRMB icon
41
Trimble
TRMB
$12.3B
$1.57M 0.2%
52,000
– –
MRK icon
42
Merck
MRK
$324B
$1.5M 0.19%
26,646
+115
+0.4% +$6.73K
SYK icon
43
Stryker
SYK
$127B
$1.39M 0.18%
11,600
– –
MKL icon
44
Markel Group
MKL
$25B
$1.29M 0.17%
1,423
– –
IBB icon
45
iShares Biotechnology ETF
IBB
$9.31B
$1.26M 0.16%
+14,304
New +$1.3M
VEA icon
46
Vanguard FTSE Developed Markets ETF
VEA
$226B
$1.26M 0.16%
34,590
-28,504
-45% -$1.04M
BRK.A icon
47
Berkshire Hathaway Class A
BRK.A
$1.07T
$1.22M 0.16%
5
– –
SBUX icon
48
Starbucks
SBUX
$118B
$1.11M 0.14%
20,049
– –
XLY icon
49
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.4B
$1.1M 0.14%
26,930
-2,000
-7% -$80.8K
ADP icon
50
Automatic Data Processing
ADP
$100B
$1.09M 0.14%
10,563
-15
-0.1% -$1.4K
1
2
3 4 5

Similar funds

NC
Nicholas Company Milwaukee, Wisconsin $5.1B AUM 8.43% 1-Year Est. Return
EIC
Equity Investment Corp Atlanta, Georgia $5.11B AUM 8.63% 1-Year Est. Return
AC
AKO Capital London, United Kingdom $5.11B AUM 2.56% 1-Year Est. Return
VT
Vise Technologies New York $5.09B AUM 22.62% 1-Year Est. Return
CIA
Choate Investment Advisors Boston, Massachusetts $5.11B AUM 17.2% 1-Year Est. Return
TAM
Todd Asset Management Louisville, Kentucky $5.11B AUM 34.73% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Cannell & Spears's Q4 2016 Portfolio in Review

As of Q4 2016, Cannell & Spears held 142 positions worth $779M, down 2% from $795M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Cannell & Spears withdrew a net $52.7M in Q4 2016, closing 10 positions and reducing 57 holdings. Its most notable exit was Abbott, an estimated $583K position sold in full.

By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 26% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Cannell & Spears opened a new position in Adient worth $1.64M.

  • Cannell & Spears's largest Q4 2016 buy was Adient: 27,920 shares worth $1.64M.
  • Cannell & Spears added most to Hershey in Q4 2016, an estimated $537K increase.
  • Cannell & Spears's biggest Q4 2016 reduction was Allergan plc, cutting an estimated $7.69M.
  • Cannell & Spears fully exited Abbott in Q4 2016, selling an estimated $583K.
  • Cannell & Spears's ten largest holdings make up 46% of its $779M portfolio in Q4 2016.
  • Cannell & Spears opened 15 new positions and closed 10 in Q4 2016.
  • Cannell & Spears's portfolio value fell 2% quarter-over-quarter to $779M.

Based on Cannell & Spears's 13F filing for Q4 2016, filed 13 Feb 2017.